Readmission in COPD patients: should we consider it a marker of quality of care or a marker of a more severe disease with a worse prognosis?

Eur Respir J. 2016 Jul;48(1):281-2. doi: 10.1183/13993003.00885-2016.

Authors

Sylvia Hartl¹, Jose Luis Lopez-Campos²

Affiliations

¹ Ludwig Boltzmann Institute of COPD and Respiratory Epidemiology, Vienna, Austria Dept. of Resp. and Crit. Care, Otto Wagner Hospital, Vienna, Austria hartl.sylvia@aon.at.
² Unidad Médico-Quirúrgica de Enfermedades Respiratorias, Hospital Universitario Virgen del Rocío, Seville, Spain CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain.

PMID: 27365514
DOI: 10.1183/13993003.00885-2016

No abstract available

Publication types

Letter
Comment

MeSH terms

Biomarkers
Humans
Patient Readmission*
Prognosis
Pulmonary Disease, Chronic Obstructive*
Quality of Health Care

Substances

Biomarkers